Expert judges determining the best of the best in healthcare innovation recognized OMRON Healthcare for its blood pressure ...
The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...
The NE-C801 CompAir® is the smallest, lightest, most convenient tabletop nebulizer – ever. Omron’s advanced design and engineering allows it to administer medication as effectively as table top models ...
Omron is undervalued by 31%, presenting a strong buy opportunity due to excessive market pessimism and resilient fundamentals in automation and healthcare. The company boasts leading positions in ...
The global nebulizers market was valued at US$ 1 billion in 2020. It is estimated to expand at a CAGR of 6.6% from 2021 to 2028, reaching approximately US$ 1.7 billion by the end of 2028. The ...
The NE-C30 CompAir® Elite compact compressor nebulizer has a small footprint and is packaged with a carrying case, nebulizer kit, mouthpiece, air tube, extra filters, child mask, multi-lingual ...
This study examined how multidimensional social relationships influence social attention in rhesus macaques, linking individual and group-level behaviors to attentional processes. The findings that ...
Omron, a Japanese manufacturer of medical devices, is experiencing record sales of blood pressure monitors in India after the Covid-19 pandemic, the company’s chief told News18. This surge is ...
Japanese medical device-maker Omron - best known for its digital blood pressure monitoring machines - will look to make operational its first India facility by March 2025. The facility is coming up at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback